394 related articles for article (PubMed ID: 16861972)
1. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
2. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
3. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
Hill CB; Yeh IT
Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
[TBL] [Abstract][Full Text] [Related]
4. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
5. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of intracystic papillary carcinoma of the breast].
Yang WT; Yu L; Lu HF; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):234-7. PubMed ID: 18844031
[TBL] [Abstract][Full Text] [Related]
8. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain.
Kalof AN; Tam D; Beatty B; Cooper K
J Clin Pathol; 2004 Jun; 57(6):625-9. PubMed ID: 15166269
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
11. Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
[TBL] [Abstract][Full Text] [Related]
12. Encapsulated papillary carcinoma (EPC) of breast: A clinical, pathological and immunohistochemical analysis of eight cases.
Tariq N; Mamoon N; Usman M; Ali Z; Nazir I
J Pak Med Assoc; 2016 Nov; 66(11):1490-1493. PubMed ID: 27812076
[TBL] [Abstract][Full Text] [Related]
13. Composite encapsulated papillary carcinoma and solid papillary carcinoma.
Cui X; Wei S
Pathol Int; 2015 Mar; 65(3):133-7. PubMed ID: 25545718
[TBL] [Abstract][Full Text] [Related]
14. Breast intracystic papillary carcinoma: an update.
Calderaro J; Espie M; Duclos J; Giachetti S; Wehrer D; Sandid W; Cahen-Doidy L; Albiter M; Janin A; de Roquancourt A
Breast J; 2009; 15(6):639-44. PubMed ID: 19735389
[TBL] [Abstract][Full Text] [Related]
15. A case of intracystic apocrine papillary tumor: diagnostic pitfalls for malignancy.
Hayashi H; Ohtani H; Yamaguchi J; Shimokawa I
Pathol Res Pract; 2013 Dec; 209(12):808-11. PubMed ID: 24095109
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
[TBL] [Abstract][Full Text] [Related]
18. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases.
Rakha EA; Abbas A; Sheeran R
Pathobiology; 2016; 83(5):221-7. PubMed ID: 27116593
[TBL] [Abstract][Full Text] [Related]
19. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study.
Leal C; Costa I; Fonseca D; Lopes P; Bento MJ; Lopes C
Hum Pathol; 1998 Oct; 29(10):1097-104. PubMed ID: 9781648
[TBL] [Abstract][Full Text] [Related]
20. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
Dabbs DJ; Gown AM
Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
